关键信息
-
基因名
TSEN15
- 应用
-
别名
TSEN15；C1orf19；tRNA-splicing endonuclease subunit Sen15
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8WW01
-
表达区间
1-171aa
-
氨基酸序列
MEERGDSEPT PGCSGLGPGG VRGFGDGGGA PSWAPEDAWM GTHPKYLEMM ELDIGDATQV YVAFLVYLDL MESKSWHEVN CVGLPELQLI CLVGTEIEGE GLQTVVPTPI TASLSHNRIR EILKASRKLQ GDPDLPMSFT LAIVESDSTI VYYKLTDGFM LPDPQNISLR R
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
TSEN15, a component of the tRNA splicing endonuclease complex, plays a vital role in the maturation of tRNA molecules by facilitating the removal of intronic sequences through a precise splicing mechanism. Mutations in the TSEN15 gene have been associated with neurodegenerative disorders, particularly with pontocerebellar hypoplasia (PCH), which is characterized by developmental delays and neurological deficits. Research into TSEN15 recombinant proteins aims to elucidate its functional mechanisms and interactions within the tRNA splicing pathway, ultimately contributing to a better understanding of the pathogenesis of related diseases. By producing and characterizing recombinant TSEN15, scientists can investigate its structural properties, enzymatic activity, and the impact of various mutations, thereby facilitating the development of potential therapeutic strategies. These studies are significant not only for basic science but also for clinical applications, as they may lead to insights into targeted treatments for the patients affected by TSEN15-related disorders. The ongoing research into TSEN15 underscores the importance of unraveling the complexities of tRNA biogenesis and its implications in human health.
